
-
Germany suspends arms exports to Israel for use in Gaza
-
Stocks waver, gold futures hit record on US tariff updates
-
Guessand says he jumped at chance to join Aston Villa after sealing move
-
Israel to 'take control' of Gaza City, sparking wave of criticism
-
Accumulating bitcoin a risky digital rush by companies?
-
Liverpool's Slot hints at fresh Isak bid despite 'attacking power'
-
PSG to sign Lille goalkeeper Lucas Chevalier: source
-
Oil industry presence surges at UN plastic talks: NGOs
-
Kipyegon says a woman will run a sub-four minute mile
-
Tokyo soars on trade deal relief as most Asian markets limp into weekend
-
Israel to 'take control' of Gaza City after approving new war plan
-
Australian A-League side Western United stripped of licence
-
'Back home': family who fled front buried after Kyiv strike
-
Indonesia cracks down on pirate protest flag
-
Israeli army will 'take control' of Gaza City: PM's office
-
Australian mushroom murderer accused of poisoning husband
-
Coventry's mettle tested by Russian Olympic debate, say former IOC figures
-
Library user borrows rare Chinese artwork, returns fakes: US officials
-
Parisians hot under the collar over A/C in apartments
-
Crypto group reportedly says it planned sex toy tosses at WNBA games
-
American Shelton tops Khachanov to win first ATP Masters title in Toronto
-
Tokyo soars on trade deal relief as Asian markets limp into weekend
-
New species teem in Cambodia's threatened karst
-
Australian mushroom murderer accused of poisoning husband: police
-
Solid gold, royal missives and Nobel noms: how to win Trump over
-
Canadian teen Mboko outlasts Osaka to win WTA Montreal crown
-
Trump to host Armenia, Azerbaijan for historic 'Peace Signing'
-
Israeli airline's Paris offices daubed with red paint, slogans
-
US raises bounty on Venezuela's Maduro to $50 mn
-
Lebanon cabinet meets again on Hezbollah disarmament
-
France's huge wildfire will burn for days: authorities
-
Bolivia right-wing presidential hopeful vows 'radical change'
-
Trump says would meet Putin without Zelensky sit-down
-
Trump offers data to justify firing of labor stats chief
-
Bhatia leads by one at PGA St. Jude, Scheffler five adrift
-
Disney settles Trump-supporting 'Star Wars' actor lawsuit
-
Trump moves to kill $7 billion in solar panel grants
-
Venus Williams falls at first hurdle in Cincinnati
-
Mixed day for global stocks as latest Trump levies take effect
-
SpaceX agrees to take Italian experiments to Mars
-
US judge orders temporary halt to new 'Alligator Alcatraz' construction
-
US uses war rhetoric, Superman to recruit for migrant crackdown
-
US to rewrite its past national climate reports
-
U can't pay this: MC Hammer sued over delinquent car loan
-
WHO says nearly 100,000 struck with cholera in Sudan
-
Huge wildfire in southern France now under control
-
Kane scores as Bayern thump Spurs in pre-season friendly
-
France strikes down return of banned bee-killing pesticide
-
Canada sends troops to eastern province as fire damage grows
-
OpenAI releases ChatGPT-5 as AI race accelerates
SCU | 0% | 12.72 | $ | |
RBGPF | -5.79% | 71.84 | $ | |
CMSD | -0.09% | 23.52 | $ | |
NGG | -0.31% | 72.08 | $ | |
RIO | 1.12% | 60.77 | $ | |
CMSC | 0.04% | 22.96 | $ | |
RYCEF | -0.42% | 14.44 | $ | |
VOD | -0.36% | 11.26 | $ | |
RELX | 1.03% | 49.32 | $ | |
BTI | 0.51% | 56.69 | $ | |
SCS | 0.06% | 16 | $ | |
GSK | 2.21% | 37.58 | $ | |
BCE | 2.23% | 23.78 | $ | |
BCC | 0.32% | 83.19 | $ | |
JRI | 0.52% | 13.41 | $ | |
AZN | 1.3% | 74.57 | $ | |
BP | 0.91% | 34.19 | $ |

Vibrating pill, ingestible sensor: mini robots tackle gut disorders
A pill that vibrates to relieve constipation, a sensor that can be tracked in the gut -- medical researchers are turning to tiny robots to treat or diagnose gastrointestinal disorders.
"This is a very booming field," said Saransh Sharma, a doctoral student at the California Institute of Technology (Caltech) involved in the development of the ingestible diagnostic sensor.
"You have medical robots that are so small you can just send them inside a person using the oral passage and they can do a lot of sensing and actuation inside the gut," Sharma told AFP.
About 16 of every 100 adults in the United States suffer from symptoms of constipation, according to the US health authorities, and the number doubles for Americans over the age of 60.
Researchers at the Massachusetts Institute of Technology (MIT) and Caltech have developed an ingestible sensor that can be monitored as it travels through the digestive tract.
The device, 20 millimeters in length and eight mm in diameter, could help physicians diagnose gastrointestinal motility disorders that prevent food from moving normally through the digestive tract.
The capsule's location reveals where a slowdown is taking place.
"That gives the doctor a lot of the essential information to do a better job in the curing and the diagnosis and the treatment plan," Sharma said.
The sensor could also provide an alternative to invasive procedures such as endoscopy or other diagnostic techniques such as nuclear imaging, X-rays or catheters.
It has been tested on pigs and the team behind the research hopes to eventually obtain the approval of the US Food and Drug Administration for human clinical trials.
"If we can demonstrate a device inside large animals like pigs up to a very high confidence, we can say that it will scale very well in human anatomy as well," Sharma said.
The authors published the results of their research on Monday in the journal Nature Electronics.
They said the sensor works by detecting a magnetic field produced by an electromagnetic coil located outside of the body.
The strength of the magnetic field varies with distance from the coil and the sensor's position within the digestive tract can be calculated to within millimeters based on measurement of the magnetic field.
- Vibrating capsule -
While the ingestible sensor is still in the development phase, an Israeli company called Vibrant Gastro recently began marketing a vibrating capsule in the United States designed to relieve chronic constipation.
The drug-free Vibrant capsule is intended for constipation sufferers who have not received bowel relief after a month of laxative treatments. It has been FDA-approved.
In a Phase 3 clinical trial of 300 people, participants who took Vibrant had bowel movements significantly more frequently than those who took a placebo.
The Vibrant capsule produces gentle vibrations to stimulate the colon and increases the number and frequency of bowel movements, according to the manufacturer.
F.AbuZaid--SF-PST